- Home
- TXRH vs ASND Comparison
TXRH vs ASND Comparison
Compare TXRH & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TXRH | ASND |
|---|---|---|
| Founded | 1993 | 2006 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.7B | 12.2B |
| IPO Year | 2004 | 2015 |
Fundamental Metrics
Financial Performance| Metric | TXRH | ASND |
|---|---|---|
| Price | $170.89 | $210.18 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 15 |
| Target Price | $189.47 | ★ $256.27 |
| AVG Volume (30 Days) | ★ 1.2M | 565.1K |
| Earning Date | 11-06-2025 | 11-12-2025 |
| Dividend Yield | ★ 1.59% | N/A |
| EPS Growth | ★ 12.56 | N/A |
| EPS | ★ 6.55 | N/A |
| Revenue | ★ $5,833,958,000.00 | $758,592,045.00 |
| Revenue This Year | $11.74 | $104.98 |
| Revenue Next Year | $10.04 | $79.91 |
| P/E Ratio | $26.10 | ★ N/A |
| Revenue Growth | 14.40 | ★ 97.46 |
| 52 Week Low | $148.73 | $118.03 |
| 52 Week High | $205.11 | $223.19 |
Technical Indicators
Market Signals| Indicator | TXRH | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 50.94 | 54.81 |
| Support Level | $165.70 | $203.02 |
| Resistance Level | $178.68 | $218.50 |
| Average True Range (ATR) | 4.06 | 10.28 |
| MACD | 0.81 | 0.31 |
| Stochastic Oscillator | 57.11 | 64.19 |
Price Performance
Historical ComparisonAbout TXRH Texas Roadhouse Inc.
Texas Roadhouse Inc is a restaurant company operating predominantly in the casual dining segment. The company manages its restaurant and franchising operations by concept and, as a result, has identified Texas Roadhouse, Bubba's 33, Jaggers, and retail initiatives as separate operating segments. In addition, it has identified Texas Roadhouse and Bubba's 33 as reportable segments. Maximum revenue for the company is generated from the Texas Roadhouse segment, which is a moderately priced, full-service, casual dining restaurant concept offering steaks, a selection of ribs, seafood, chicken, pork chops, pulled pork, vegetable plates, and an assortment of hamburgers, salads, and sandwiches.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.